TORONTO, May 12 /PRNewswire/ -- DiaSorin, a global provider of clinical in-vitro diagnostic medical devices, has turned to Dyadem to improve its risk assessment and ensure the quality of its medical devices. Dyadem, a leader in Quality Lifecycle Management and Risk Lifecycle Management solutions, is assisting DiaSorin through the use of its FMEA-Med software to improve its risk assessment processes and ensure regulatory compliance.
FMEA-Med is a software solution that delivers Failure Mode and Effects Analysis (FMEA) for medical devices and pharmaceutical manufacturers. Dyadem solutions improve quality and prevent potential flaws in hardware design, manufacturing and processes in a variety of industries, including aerospace, chemical and automotive. DiaSorin selected FMEA-Med to improve product designs analysis for defects, and to optimize manufacturing processes by creating consistent quality standard templates that are used throughout the company's headquarters in Italy and facilities in Germany and the United States. These templates bring a unified methodology to DiaSorin's worldwide processes and standardize risk management.
The global scale of DiaSorin's operations require the company to comply with a host of domestic and international quality regulations, including the IVD Directive, CE Marking, ISO 14971 and various Food and Drug Administration requirements in the United States. These regulations require documentation of risk assessment procedures and monitor the quality of incoming medical devices. For example, the FDA requires the inspection of foreign medical supply facilities before their products are sold in the United States.
DiaSorin's facilities operate independently from each other, but needed a common way to assess risk and unify compliance. Individual teams are able to improve their efficiency through the use of standard Dyadem templates used across the organization. Previously, DiaSorin was using standard spreadsheet programs that allowed few customizations for medical device manufacturers. Now, DiaSorin is able to transfer knowledge and processes across facilities, allowing for easy adjustments to changes in production locations. The result is a unified approach to quality.
When evaluating potential solutions, DiaSorin used Dyadem Web demonstrations to view FMEA-Med's capabilities. DiaSorin is now working with Dyadem experts on-site to deploy the software, create process templates and train staff.
"Last year alone, the U.S. FDA issued 20 recalls of medical devices . an alarming increase compared with five years ago. DiaSorin is leading its industry in setting high standards for quality and ensuring consumer safety," said Kevin North, president and CEO of Dyadem. "With the world's top ten medical device manufacturers on our client list, Dyadem understands the unique needs of medical device companies and the scrutiny they are under. We are working closely with our customers to ensure that medical device quality is not an afterthought. "
Founded in 1993, Dyadem is the market leader in Quality Lifecycle Management and Risk Lifecycle Management solutions. Dyadem provides software and services that empower companies to manage quality, mitigate risks, achieve regulatory compliance, plan for business continuity and improve profitability. Dyadem works with 85% of the Fortune 500 companies and serves the high tech & electronics, medical devices, oil and gas, chemical, automotive, pharmaceutical and aerospace and defense industries. For more information, visit www.dyadem.com
CONTACT: Angela Schwecke of Dyadem, +1-905-762-5243, firstname.lastname@example.org,
or Greg Sabey of Text 100 Public Relations, +1-617-399-4909,
email@example.com, for Dyadem
Web site: http://www.dyadem.com/